cerrar
Tagged with Trials,

Interview: Carolina Galicia – Country Manager, World…
Carolina Galicia explains how World Courier Mexico has strengthened its leadership position for clinical trials logistics and leveraged its…

Interview: Gerardo Cárdenas Vogel – CEO, Innovare R&D,…
Gerardo Cárdenas Vogel, CEO of Innovare R&D, on transforming the company’s business model to benefit from drug development opportunities,…

Interview: Prof. Dr. med. Adriano Aguzzi – Director,…
Prof. Dr. med. Adriano Aguzzi provides insight on the past, present, and future of prion and antibody therapy research in Switzerland. The Institute…

Interview: Prof. Jürg Utzinger – Director, Swiss Tropical…
Professor Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) emphasizes the importance of partnerships and sharing…

Number of Clinical Trials in Italy
The following chart shows the number of clinical trials in Italy per year. Peaking in 2008 and slumping slightly shortly after, the numbers have…

Interview: Dr. Juan Francisco Millan Soberanes – Director…
Juan Fransisco Millán Sobaranes of Cetifarma, the council created by the pharmaceutical industry in Mexico for ethics and transparency, discussed the…

Interview: Matthieu Brand – Managing Director, World…
Matthieu Brand, who has been heading the French affiliate of World Courier, AmerisourceBergen for 2.5 years now, shares with great passion the bright…

Interview: Heidrun Irschik – CPO Head & Country…
The country president of Novartis Czech Republic explains the strategy that led the affiliate to become the number one pharmaceutical company in the…

Interview: György Bodoky – Head of Oncology, Unified Szent…
György Bodoky, Head of the Oncology Department at Unified Szent István and Szent László Hospital, shares his insights on the state of oncological…

Interview: Dr. Jan Frederic Kesselhut – CEO, Servier…
The recently appointed CEO of Servier Hungary, Dr. Jan Frederic Kesselhut highlights his initial perceptions of the Hungarian pharmaceutical market…

South African Clinical Trials: Turning Diversity into Opportunity
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease profiles—these seem to be the fundamentals…

Interview: Peter Schoevers – CEO & Co-Founder, Julius…
Peter Schoevers, CEO and co-founder of Julius Clinical, explains how this innovative and thriving organization allies the academic strength of an ARO…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here